MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 329608 | Name: Diazaborine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Diazaborine, also known as SA 84474, is a chemical compound that inhibits maturation of rRNAs for the large ribosomal subunit. Diazaborine blocks ribosome biogenesis by inhibiting the AAA-ATPase Drg1. Diazaborine treatment causes, within minutes, a rapid redistribution of the protein from the nucleolus to the periphery of the nucleus, which provides a possible explanation for the effect of diazaborine on rRNA processing.

Chemical Structure

Diazaborine
CAS#22959-81-5

Theoretical Analysis

MedKoo Cat#: 329608

Name: Diazaborine

CAS#: 22959-81-5

Chemical Formula: C14H13BN2O3S

Exact Mass: 300.0740

Molecular Weight: 300.14

Elemental Analysis: C, 56.03; H, 4.37; B, 3.60; N, 9.33; O, 15.99; S, 10.68

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Diazaborine; Diazaborine compound 2b18; Pkf 84.474; Pkf-84474; Pkf 84474; SA-84474; SA84474; SA 84474.
IUPAC/Chemical Name
1-Hydroxy-2-(4-methylphenyl)sulfonyl-2,3,1-benzodiazaborinine
InChi Key
UQIDNSKBUXCODH-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H13BN2O3S/c1-11-6-8-13(9-7-11)21(19,20)17-15(18)14-5-3-2-4-12(14)10-16-17/h2-10,18H,1H3
SMILES Code
O=S(N1B(O)C2=CC=CC=C2C=N1)(C3=CC=C(C)C=C3)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 300.14 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Bandyopadhyay A, Cambray S, Gao J. Fast Diazaborine Formation of Semicarbazide Enables Facile Labeling of Bacterial Pathogens. J Am Chem Soc. 2017 Jan 18;139(2):871-878. doi: 10.1021/jacs.6b11115. PubMed PMID: 27992180. 2: Ward MS, Silva I, Martinez W, Jefferson J, Rahman S, Garcia JM, Kanichar D, Roppiyakuda L, Kosmowska E, Faust MA, Tran KP, Chow F, Buglo E, Zhou F, Groziak MP, Xu HH. Identification of cellular targets of a series of boron heterocycles using TIPA II-A sensitive target identification platform. Bioorg Med Chem. 2016 Aug 1;24(15):3267-75. doi: 10.1016/j.bmc.2016.05.058. PubMed PMID: 27301675; PubMed Central PMCID: PMC4992540. 3: Jordan CA, Sandoval BA, Serobyan MV, Gilling DH, Groziak MP, Xu HH, Vey JL. Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors. Acta Crystallogr F Struct Biol Commun. 2015 Dec;71(Pt 12):1521-30. doi: 10.1107/S2053230X15022098. PubMed PMID: 26625295; PubMed Central PMCID: PMC4666481. 4: Kim EJ, Lee JK. Effect of changes in the composition of cellular fatty acids on membrane fluidity of Rhodobacter sphaeroides. J Microbiol Biotechnol. 2015 Feb;25(2):162-73. PubMed PMID: 25418478. 5: Kanichar D, Roppiyakuda L, Kosmowska E, Faust MA, Tran KP, Chow F, Buglo E, Groziak MP, Sarina EA, Olmstead MM, Silva I, Xu HH. Synthesis, characterization, and antibacterial activity of structurally complex 2-acylated 2,3,1-benzodiazaborines and related compounds. Chem Biodivers. 2014 Sep;11(9):1381-97. doi: 10.1002/cbdv.201400007. PubMed PMID: 25238079. 6: Silva I, Real LJ, Ward MS, Xu HH. A disk-diffusion-based target identification platform for antibacterials (TIPA): an inducible assay for profiling MOAs of antibacterial compounds. Appl Microbiol Biotechnol. 2014 Jun;98(12):5551-66. doi: 10.1007/s00253-014-5623-9. PubMed PMID: 24622888. 7: Loibl M, Klein I, Prattes M, Schmidt C, Kappel L, Zisser G, Gungl A, Krieger E, Pertschy B, Bergler H. The drug diazaborine blocks ribosome biogenesis by inhibiting the AAA-ATPase Drg1. J Biol Chem. 2014 Feb 14;289(7):3913-22. doi: 10.1074/jbc.M113.536110. PubMed PMID: 24371142; PubMed Central PMCID: PMC3924260. 8: Pertschy B, Saveanu C, Zisser G, Lebreton A, Tengg M, Jacquier A, Liebminger E, Nobis B, Kappel L, van der Klei I, Högenauer G, Fromont-Racine M, Bergler H. Cytoplasmic recycling of 60S preribosomal factors depends on the AAA protein Drg1. Mol Cell Biol. 2007 Oct;27(19):6581-92. PubMed PMID: 17646390; PubMed Central PMCID: PMC2099225. 9: Pertschy B, Zisser G, Schein H, Köffel R, Rauch G, Grillitsch K, Morgenstern C, Durchschlag M, Högenauer G, Bergler H. Diazaborine treatment of yeast cells inhibits maturation of the 60S ribosomal subunit. Mol Cell Biol. 2004 Jul;24(14):6476-87. PubMed PMID: 15226447; PubMed Central PMCID: PMC434233. 10: Wehrschütz-Sigl E, Jungwirth H, Bergler H, Högenauer G. The transporters Pdr5p and Snq2p mediate diazaborine resistance and are under the control of the gain-of-function allele PDR1-12. Eur J Biochem. 2004 Mar;271(6):1145-52. PubMed PMID: 15009193. 11: Johnson-Restrepo B, Pacheco-Londoño L, Olivero-Verbel J. Molecular parameters responsible for the melting point of 1,2,3-diazaborine compounds. J Chem Inf Comput Sci. 2003 Sep-Oct;43(5):1513-9. PubMed PMID: 14502485. 12: Kremer L, Dover LG, Morbidoni HR, Vilchèze C, Maughan WN, Baulard A, Tu SC, Honoré N, Deretic V, Sacchettini JC, Locht C, Jacobs WR Jr, Besra GS. Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria. J Biol Chem. 2003 Jun 6;278(23):20547-54. PubMed PMID: 12654922. 13: Gilbert P, Allison DG, McBain AJ. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? Symp Ser Soc Appl Microbiol. 2002;(31):98S-110S. Review. PubMed PMID: 12481835. 14: Lee IH, Kim EJ, Cho YH, Lee JK. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant. Biochem Biophys Res Commun. 2002 Dec 13;299(4):621-7. PubMed PMID: 12459184. 15: Gilbert P, Allison DG, McBain AJ. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? J Appl Microbiol. 2002;92 Suppl:98S-110S. Review. PubMed PMID: 12000619. 16: Levy CW, Baldock C, Wallace AJ, Sedelnikova S, Viner RC, Clough JM, Stuitje AR, Slabas AR, Rice DW, Rafferty JB. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase. J Mol Biol. 2001 May 25;309(1):171-80. PubMed PMID: 11491286. 17: Jungwirth H, Bergler H, Högenauer G. Diazaborine treatment of Baker's yeast results in stabilization of aberrant mRNAs. J Biol Chem. 2001 Sep 28;276(39):36419-24. PubMed PMID: 11477081. 18: Jungwirth H, Wendler F, Platzer B, Bergler H, Högenauer G. Diazaborine resistance in yeast involves the efflux pumps Ycf1p and Flr1p and is enhanced by a gain-of-function allele of gene YAP1. Eur J Biochem. 2000 Aug;267(15):4809-16. PubMed PMID: 10903515. 19: Roujeinikova A, Levy CW, Rowsell S, Sedelnikova S, Baker PJ, Minshull CA, Mistry A, Colls JG, Camble R, Stuitje AR, Slabas AR, Rafferty JB, Pauptit RA, Viner R, Rice DW. Crystallographic analysis of triclosan bound to enoyl reductase. J Mol Biol. 1999 Nov 26;294(2):527-35. PubMed PMID: 10610777. 20: Roujeinikova A, Sedelnikova S, de Boer GJ, Stuitje AR, Slabas AR, Rafferty JB, Rice DW. Inhibitor binding studies on enoyl reductase reveal conformational changes related to substrate recognition. J Biol Chem. 1999 Oct 22;274(43):30811-7. PubMed PMID: 10521472.